QQ客服 官方微博 反馈留言

浏览/检索结果: 共10条，第1-10条 帮助 限定条件 发表日期：2022    内容类型：期刊论文    专题：合肥物质科学研究院    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Darinaparsin (ZIO-101) enhances the sensitivity of small-cell lung cancer to PARP inhibitors (vol 0, pg 1, 2022) 期刊论文 ACTA PHARMACOLOGICA SINICA, 2022 作者:  Cao, Guo-zhen;  Ma, Li-ying;  Zhang, Zong-hui;  Wang, Xiao-lin;  Hua, Jing-han 收藏  |  浏览/下载：25/0  |  提交时间：2022/12/23 Development and validation of an autophagy-related long non-coding RNA prognostic signature for cervical squamous cell carcinoma and endocervical adenocarcinoma 期刊论文 FRONTIERS IN ONCOLOGY, 2022, 卷号: 12 作者:  Zhou, Shuguang;  Zhang, Weiyu;  Cao, Wujun;  Jin, Qinqin;  Jiang, Xiya 收藏  |  浏览/下载：257/0  |  提交时间：2022/12/23 cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC)  long noncoding RNA (lncRNA)  autophagy-related genes (ARGs)  autophagy-related lncRNAs (ARLs)  prognostic signature  immune infiltration   Darinaparsin (ZIO-101) enhances the sensitivity of small-cell lung cancer to PARP inhibitors 期刊论文 ACTA PHARMACOLOGICA SINICA, 2022 作者:  Cao, Guo-Zhen;  Ma, Li-Ying;  Zhang, Zong-Hui;  Wang, Xiao-Lin;  Hua, Jing-Han 收藏  |  浏览/下载：25/0  |  提交时间：2022/12/22 small-cell lung cancer  H3  3  PARP1  PARP inhibitor  darinaparsin  combination treatment   Tislelizumab, a PD-1 inhibitor for relapsed/refractory mature T/NK-cell neoplasms: Results from a phase 2 study. 期刊论文 JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40 作者:  Bachy, Emmanuel;  Savage, Kerry J.;  Huang, Huiqiang;  Kwong, Yok-Lam;  Gritti, Giuseppe 收藏  |  浏览/下载：28/0  |  提交时间：2022/12/23 Status and associated factors of cross-regional healthcare-seeking among patients with advanced colorectal cancer in China: a multicenter cross-sectional study 期刊论文 ANNALS OF TRANSLATIONAL MEDICINE, 2022 作者:  Zhang, Jian-Gong;  Wang, Hong;  Gu, Xiao-Fen;  Wang, Xiao-Yang;  Wang, Wen-Jun 收藏  |  浏览/下载：36/0  |  提交时间：2022/05/16 Colorectal cancer (CRC)  cross-regional healthcare-seeking  cross-sectional study   Knowledge and awareness of colorectal cancer risk factors, screening, and associated factors in advanced colorectal cancer patients: a multicenter cross-sectional study in China 期刊论文 ANNALS OF TRANSLATIONAL MEDICINE, 2022 作者:  Xu, Hui-Fang;  Gu, Xiao-Fen;  Wang, Xiao-Hui;  Wang, Wen-Jun;  Du, Ling-Bin 收藏  |  浏览/下载：31/0  |  提交时间：2022/05/16 Colorectal cancer  knowledge  awareness  patients   The choice of medical facility and associated factors among Chinese advanced colorectal cancer patients: a cross-sectional multi-center study 期刊论文 ANNALS OF TRANSLATIONAL MEDICINE, 2022 作者:  Wang, Xiao-Yang;  Wang, Wen-Jun;  Zhao, Yu-Qian;  Liu, Yin;  Wang, Xiao-Hui 收藏  |  浏览/下载：32/0  |  提交时间：2022/05/16 Colorectal cancer (CRC)  healthcare seeking  medical facility  associated factors   Utilization of genetic biomarkers testing and its associated factors in advanced colorectal cancer patients in China: a nationwide multicenter clinical epidemiological study 期刊论文 ANNALS OF TRANSLATIONAL MEDICINE, 2022 作者:  Zhang, Xi;  Lian, Xue-Mei;  Gu, Xiao-Fen;  Liu, Yin;  Feng, Chang-Yan 收藏  |  浏览/下载：32/0  |  提交时间：2022/05/16 Colorectal cancer (CRC)  biomarker  RAS  BRAF  microsatellite instability (MSI)   Health-related quality of life in advanced colorectal cancer patients in China: a nationwide hospital-based survey 期刊论文 ANNALS OF TRANSLATIONAL MEDICINE, 2022, 卷号: 10 作者:  Yu, Yan-Qin;  Ma, Li;  Wang, Wen-Jun;  Zhao, Yu-Qian;  Xu, Hui-Fang 收藏  |  浏览/下载：23/0  |  提交时间：2022/12/23 Health-related quality of life (HRQOL)  colorectal cancer (CRC)  China   Out-of-pocket medical expenditure and associated factors of advanced colorectal cancer in China: a multi-center cross-sectional study 期刊论文 ANNALS OF TRANSLATIONAL MEDICINE, 2022, 卷号: 10 作者:  Wang, Hong;  Ma, Li;  Gu, Xiao-Fen;  Li, Li;  Wang, Wen-Jun 收藏  |  浏览/下载：15/0  |  提交时间：2022/12/23 Colorectal cancer (CRC)  medical expenditure  China